Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

CEPO vs MS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CEPO
Cantor Equity Partners I, Inc. Class A Ordinary Shares

Shell Companies

Financial ServicesNASDAQ • US
Market Cap$217M
5Y Perf.+5.2%
MS
Morgan Stanley

Financial - Capital Markets

Financial ServicesNYSE • US
Market Cap$302.59B
5Y Perf.+37.4%

CEPO vs MS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CEPO logoCEPO
MS logoMS
IndustryShell CompaniesFinancial - Capital Markets
Market Cap$217M$302.59B
Revenue (TTM)$0.00$103.14B
Net Income (TTM)$-12M$16.18B
Gross Margin55.6%
Operating Margin17.1%
Forward P/E16.0x
Total Debt$486K$360.49B
Cash & Equiv.$25K$75.74B

CEPO vs MSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CEPO
MS
StockJan 25May 26Return
Cantor Equity Partn… (CEPO)100105.2+5.2%
Morgan Stanley (MS)100137.4+37.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: CEPO vs MS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MS leads in 4 of 7 categories, making it the strongest pick for profitability and margin quality and dividend income and shareholder returns. Cantor Equity Partners I, Inc. Class A Ordinary Shares is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
CEPO
Cantor Equity Partners I, Inc. Class A Ordinary Shares
The Banking Pick

CEPO is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • beta 0.08
  • Lower volatility, beta 0.08, Low D/E 0.3%, current ratio 0.26x
  • Beta 0.08, current ratio 0.26x
Best for: income & stability and sleep-well-at-night
MS
Morgan Stanley
The Banking Pick

MS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 16.8%, EPS growth 53.5%
  • 7.3% 10Y total return vs CEPO's 5.2%
  • 13.0% margin vs CEPO's 3.6%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthCEPO logoCEPO5.9% NII/revenue growth vs MS's 16.8%
ValueCEPO logoCEPOBetter valuation composite
Quality / MarginsMS logoMS13.0% margin vs CEPO's 3.6%
Stability / SafetyCEPO logoCEPOBeta 0.08 vs MS's 1.37, lower leverage
DividendsMS logoMS2.0% yield; 11-year raise streak; the other pay no meaningful dividend
Momentum (1Y)MS logoMS+63.0% vs CEPO's -9.3%
Efficiency (ROA)MS logoMS1.2% ROA vs CEPO's -5.7%, ROIC 2.9% vs -0.8%

CEPO vs MS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CEPOCantor Equity Partners I, Inc. Class A Ordinary Shares

Segment breakdown not available.

MSMorgan Stanley
FY 2024
Wealth Management Segment
45.6%$28.4B
Institutional Securities Segment
45.0%$28.1B
Investment Management Segment
9.4%$5.9B

CEPO vs MS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLMSLAGGINGCEPO

Income & Cash Flow (Last 12 Months)

MS leads this category, winning 1 of 1 comparable metric.

MS and CEPO operate at a comparable scale, with $103.1B and $0 in trailing revenue.

MetricCEPO logoCEPOCantor Equity Par…MS logoMSMorgan Stanley
RevenueTrailing 12 months$0$103.1B
EBITDAEarnings before interest/tax-$1M$26.3B
Net IncomeAfter-tax profit-$12M$16.2B
Free Cash FlowCash after capex-$1-$6.7B
Gross MarginGross profit ÷ Revenue+55.6%
Operating MarginEBIT ÷ Revenue+17.1%
Net MarginNet income ÷ Revenue+13.0%
FCF MarginFCF ÷ Revenue-2.0%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year-5.1%+48.9%
MS leads this category, winning 1 of 1 comparable metric.

Valuation Metrics

CEPO leads this category, winning 2 of 2 comparable metrics.
MetricCEPO logoCEPOCantor Equity Par…MS logoMSMorgan Stanley
Market CapShares × price$217M$302.6B
Enterprise ValueMkt cap + debt − cash$217M$587.3B
Trailing P/EPrice ÷ TTM EPS-40.65x23.92x
Forward P/EPrice ÷ next-FY EPS est.16.01x
PEG RatioP/E ÷ EPS growth rate2.69x
EV / EBITDAEnterprise value multiple25.81x
Price / SalesMarket cap ÷ Revenue2.93x
Price / BookPrice ÷ Book value/share1.39x2.91x
Price / FCFMarket cap ÷ FCF4121.21x
CEPO leads this category, winning 2 of 2 comparable metrics.

Profitability & Efficiency

Evenly matched — CEPO and MS each lead in 4 of 8 comparable metrics.

MS delivers a 14.6% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $-8 for CEPO. CEPO carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to MS's 3.42x. On the Piotroski fundamental quality scale (0–9), CEPO scores 6/9 vs MS's 5/9, reflecting solid financial health.

MetricCEPO logoCEPOCantor Equity Par…MS logoMSMorgan Stanley
ROE (TTM)Return on equity-8.1%+14.6%
ROA (TTM)Return on assets-5.7%+1.2%
ROICReturn on invested capital-0.8%+2.9%
ROCEReturn on capital employed-0.9%+3.8%
Piotroski ScoreFundamental quality 0–965
Debt / EquityFinancial leverage0.00x3.42x
Net DebtTotal debt minus cash$460,504$284.7B
Cash & Equiv.Liquid assets$25,000$75.7B
Total DebtShort + long-term debt$485,504$360.5B
Interest CoverageEBIT ÷ Interest expense0.44x
Evenly matched — CEPO and MS each lead in 4 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

MS leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in MS five years ago would be worth $23,624 today (with dividends reinvested), compared to $10,517 for CEPO. Over the past 12 months, MS leads with a +63.0% total return vs CEPO's -9.3%. The 3-year compound annual growth rate (CAGR) favors MS at 33.6% vs CEPO's 1.7% — a key indicator of consistent wealth creation.

MetricCEPO logoCEPOCantor Equity Par…MS logoMSMorgan Stanley
YTD ReturnYear-to-date+1.5%+5.7%
1-Year ReturnPast 12 months-9.3%+63.0%
3-Year ReturnCumulative with dividends+5.2%+138.4%
5-Year ReturnCumulative with dividends+5.2%+136.2%
10-Year ReturnCumulative with dividends+5.2%+732.3%
CAGR (3Y)Annualised 3-year return+1.7%+33.6%
MS leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CEPO and MS each lead in 1 of 2 comparable metrics.

CEPO is the less volatile stock with a 0.08 beta — it tends to amplify market swings less than MS's 1.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MS currently trades 97.6% from its 52-week high vs CEPO's 64.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCEPO logoCEPOCantor Equity Par…MS logoMSMorgan Stanley
Beta (5Y)Sensitivity to S&P 5000.08x1.37x
52-Week HighHighest price in past year$16.50$194.83
52-Week LowLowest price in past year$10.27$118.20
% of 52W HighCurrent price vs 52-week peak+64.1%+97.6%
RSI (14)Momentum oscillator 0–10050.166.0
Avg Volume (50D)Average daily shares traded38K5.4M
Evenly matched — CEPO and MS each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

MS is the only dividend payer here at 2.00% yield — a key consideration for income-focused portfolios.

MetricCEPO logoCEPOCantor Equity Par…MS logoMSMorgan Stanley
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$205.75
# AnalystsCovering analysts52
Dividend YieldAnnual dividend ÷ price+2.0%
Dividend StreakConsecutive years of raises11
Dividend / ShareAnnual DPS$3.81
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.4%
Insufficient data to determine a leader in this category.
Key Takeaway

MS leads in 2 of 6 categories (Income & Cash Flow, Total Returns). CEPO leads in 1 (Valuation Metrics). 2 tied.

Best OverallMorgan Stanley (MS)Leads 2 of 6 categories
Loading custom metrics...

CEPO vs MS: Frequently Asked Questions

7 questions · data-driven answers · updated daily

01

Is CEPO or MS a better buy right now?

Morgan Stanley (MS) offers the better valuation at 23.

9x trailing P/E (16. 0x forward), making it the more compelling value choice. Analysts rate Morgan Stanley (MS) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — CEPO or MS?

Over the past 5 years, Morgan Stanley (MS) delivered a total return of +136.

2%, compared to +5. 2% for Cantor Equity Partners I, Inc. Class A Ordinary Shares (CEPO). Over 10 years, the gap is even starker: MS returned +732. 3% versus CEPO's +5. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — CEPO or MS?

By beta (market sensitivity over 5 years), Cantor Equity Partners I, Inc.

Class A Ordinary Shares (CEPO) is the lower-risk stock at 0. 08β versus Morgan Stanley's 1. 37β — meaning MS is approximately 1672% more volatile than CEPO relative to the S&P 500. On balance sheet safety, Cantor Equity Partners I, Inc. Class A Ordinary Shares (CEPO) carries a lower debt/equity ratio of 0% versus 3% for Morgan Stanley — giving it more financial flexibility in a downturn.

04

Which has better profit margins — CEPO or MS?

Morgan Stanley (MS) is the more profitable company, earning 13.

0% net margin versus 0. 0% for Cantor Equity Partners I, Inc. Class A Ordinary Shares — meaning it keeps 13. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MS leads at 17. 1% versus 0. 0% for CEPO. At the gross margin level — before operating expenses — MS leads at 55. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

05

Which pays a better dividend — CEPO or MS?

In this comparison, MS (2.

0% yield) pays a dividend. CEPO does not pay a meaningful dividend and should not be held primarily for income.

06

Is CEPO or MS better for a retirement portfolio?

For long-horizon retirement investors, Cantor Equity Partners I, Inc.

Class A Ordinary Shares (CEPO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 08)). Both have compounded well over 10 years (CEPO: +5. 2%, MS: +732. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

07

What are the main differences between CEPO and MS?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CEPO is a small-cap quality compounder stock; MS is a large-cap high-growth stock. MS pays a dividend while CEPO does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

CEPO

Quality Business

  • Sector: Financial Services
  • Market Cap > $100B
Run This Screen
Stocks Like

MS

High-Growth Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 8%
  • Net Margin > 7%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.